The largest database of trusted experimental protocols

5 protocols using recombinant human gm csf

1

Monocyte-derived Dendritic Cell Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Buffy coats from healthy donors who consented to their use for scientific research were obtained from local blood donations. The study received approval from the Hôpital Erasme Ethics Committee (Route de Lennik 808, B-1070 Brussels). Peripheral blood mononuclear cells (PBMCs) were purified by density gradient centrifugation (Lymphoprep—Stemcell Technologies). CD14+ monocytes were purified from PBMCs by positive magnetic separation with anti-CD14 microbeads (Automacs—Miltenyi Biotec) and cultured in 75-cm2 flasks with 20 ml of medium (RPMI containing 10% FCS, penicillin/streptomycin, non-essential amino acids, and glutamine) supplemented with recombinant human GM-CSF (800 U/ml—Gentaur) and IL-4 (200 U/ml—Wittycell). After 3 days, 16,000 U GM-CSF and 4,000 U IL-4 were added to the medium. At day 6–7, non-adherent cells corresponding to DCs (>90% CD14-negative HLA-DR-positive CD11c-positive) were recovered, washed, and used for subsequent experiments.
+ Open protocol
+ Expand
2

Quantitative Antibody Binding ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total IgGs were quantified using 96-well MaxiSorp plates (Nunc) coated with goat
anti-human IgG (SouthernBiotech, 2040-01) using Certified Reference Material 470
(ERMs-DA470, Sigma-Aldrich) as a standard. To test specific binding of antibody
constructs, ELISA plates were coated with 2 μg ml−1 of type I
recombinant human collagen (Millipore, CC050), 2 μg ml−1 of an
anti-human LAIR1 antibody (clone DX26, BD Biosciences 550810), 1 μg
ml−1 of recombinant human GM-CSF (Gentaur), 2 μg
ml−1 of an anti-PD1 or an anti-SLAM antibody (R&D Systems,
AF1086 and AF164). Plates were blocked with 1% bovine serum albumin (BSA) and incubated
with titrated antibodies, followed by AP-conjugated goat anti-human IgG, Fcγ
fragment specific (Jackson Immuno Research, 109-056-098). Plates were then washed,
substrate (p-NPP, Sigma) was added and plates were read at 405 nm.
+ Open protocol
+ Expand
3

Purification and Quantification of Anti-GM-CSF Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mAbs and total IgG from PAP sera were purified by protein A or protein G chromatography (GE Healthcare). Total IgG from healthy donors were purified using the HiTrap Protein A HP columns (GE Healthcare) and concentrated using Amicon Ultra filter units (100 K, Millipore). Total GM-CSF antibodies were affinity-purified from PAP sera using magnetic beads (Invitrogen) conjugated with human GM-CSF. Total IgGs were quantified using ELISA plates coated with anti-human IgG (SouthernBiotech) using Certified Reference Material 470 (ERMs-DA470, Sigma-Aldrich) as standard. Binding to GM-CSF was tested by ELISA using 384-well SpectraPlates (PerkinElmer) for primary screenings or 96-well MaxiSorp plates (Nunc) for any following test. Briefly, ELISA plates were coated with 1 μg ml−1 of recombinant human GM-CSF (Gentaur), blocked with 1% BSA and incubated with titrated antibodies, followed by AP-conjugated anti-human IgG secondary antibodies (SouthernBiotech). Plates were then washed, substrate (p-NPP, Sigma) was added and plates were read at 405 nm. EC50 (ng ml−1) was calculated for every sample by nonlinear regression analysis using the GraphPad Prism 5 software.
+ Open protocol
+ Expand
4

Quantitative Antibody Binding ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total IgGs were quantified using 96-well MaxiSorp plates (Nunc) coated with goat
anti-human IgG (SouthernBiotech, 2040-01) using Certified Reference Material 470
(ERMs-DA470, Sigma-Aldrich) as a standard. To test specific binding of antibody
constructs, ELISA plates were coated with 2 μg ml−1 of type I
recombinant human collagen (Millipore, CC050), 2 μg ml−1 of an
anti-human LAIR1 antibody (clone DX26, BD Biosciences 550810), 1 μg
ml−1 of recombinant human GM-CSF (Gentaur), 2 μg
ml−1 of an anti-PD1 or an anti-SLAM antibody (R&D Systems,
AF1086 and AF164). Plates were blocked with 1% bovine serum albumin (BSA) and incubated
with titrated antibodies, followed by AP-conjugated goat anti-human IgG, Fcγ
fragment specific (Jackson Immuno Research, 109-056-098). Plates were then washed,
substrate (p-NPP, Sigma) was added and plates were read at 405 nm.
+ Open protocol
+ Expand
5

Purification and Quantification of GM-CSF Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mAbs and total IgG from PAP sera were purified by protein A or protein G chromatography (GE Healthcare). Total IgG from healthy donors were purified by HiTrap Protein A HP columns (GE Healthcare) and concentrated by Amicon Ultra filter units (100K, Millipore). Total GM-CSF antibodies were affinity-purified from PAP sera using magnetic beads (Invitrogen) conjugated with human GM-CSF. Total IgGs were quantified by ELISA plates coated with anti-human IgG (SouthernBiotech) using Certified Reference Material 470 (ERMs-DA470, Sigma-Aldrich) as standard. Binding to GM-CSF was tested by ELISA using 384-well SpectraPlates (PerkinElmer) for primary screenings or 96-well MaxiSorp plates (Nunc) for any following test. Briefly, ELISA plates were coated with 1 μg ml−1 of recombinant human GM-CSF (Gentaur), blocked with 1% BSA and incubated with titrated antibodies, followed by AP-conjugated anti-human IgG secondary antibodies (SouthernBiotech). Plates were then washed, substrate (p-NPP, Sigma) was added and plates were read at 405 nm. EC50 (ng ml−1) was calculated for every sample by nonlinear regression analysis using GraphPad Prism 5 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!